| Literature DB >> 30364276 |
Robert Coben1, Morgan Middlebrooks1, Howard Lightstone2, Madeleine Corbell3.
Abstract
As the field of neurofeedback and neuromodulation grows, trends toward using neurofeedback to treat problems of brain dysfunction have emerged. While the use of connectivity based fMRI guided neurofeedback has shown itself to be efficacious, the expense related to the treatment calls for a more practical solution. The use of QEEG guided neurofeedback in the treatment has shown promise as an emerging treatment. To date, EEG based neurofeedback approaches have used technology with limited sophistication. We designed a new form of neurofeedback that uses four channels of EEG with a multivariate calculation of coherence metrics. Following a mathematical presentation of this model, we present findings of a multi-site study with clinical subjects with various diagnoses. We compared this form of multivariate coherence neurofeedback to the more standard two channel coherence training. Findings showed that there was a significant difference between the groups with four channel multivariate coherence neurofeedback leading to greater changes in EEG metrics. Compared to two channel coherence training, four channel multivariate coherence neurofeedback led to a greater than 50% change in power and 400% in coherence values per session. The significance of these findings is discussed in relation to complex calculations of effective connectivity and how this might lead to even greater enhancements in neurofeedback efficacy.Entities:
Keywords: EEG; QEEG; coherence; connectivity; neurofeedback; neuromodulation
Year: 2018 PMID: 30364276 PMCID: PMC6193115 DOI: 10.3389/fnins.2018.00729
Source DB: PubMed Journal: Front Neurosci ISSN: 1662-453X Impact factor: 4.677
Frequency of participant diagnoses.
| Diagnosis | Frequency | % | Valid % | Cumulative % |
|---|---|---|---|---|
| ADHD | 29 | 16.7 | 16.7 | 16.7 |
| ADHD and LD | 5 | 2.9 | 2.9 | 19.5 |
| ADHD, LD, and anxiety disorder | 1 | 0.6 | 0.6 | 20.1 |
| Anoxia | 1 | 0.6 | 0.6 | 20.7 |
| Anxiety | 3 | 1.7 | 1.7 | 22.4 |
| APD | 3 | 1.7 | 1.7 | 24.1 |
| ASD | 53 | 30.5 | 30.5 | 54.6 |
| ASD and LD | 4 | 2.3 | 2.3 | 56.9 |
| Auditory processing disorder and LD | 1 | 0.6 | 0.6 | 57.5 |
| Bipolar disorder | 1 | 0.6 | 0.6 | 58.0 |
| Cognitive disorder | 2 | 1.1 | 1.1 | 59.2 |
| Cognitive disorder | 8 | 4.6 | 4.6 | 63.8 |
| Cognitive disorder and depression | 2 | 1.1 | 1.1 | 64.9 |
| Concussions | 1 | 0.6 | 0.6 | 65.5 |
| CVA | 2 | 1.1 | 1.1 | 66.7 |
| Depression | 10 | 5.7 | 5.7 | 72.4 |
| Developmental delays | 2 | 1.1 | 1.1 | 73.6 |
| Epilepsy | 8 | 4.6 | 4.6 | 78.2 |
| Language disorder and anxiety | 1 | 0.6 | 0.6 | 78.7 |
| Language disorder and LD | 1 | 0.6 | 0.6 | 79.3 |
| Learning disability | 13 | 7.5 | 7.5 | 86.8 |
| LD and depression | 1 | 0.6 | 0.6 | 87.4 |
| OCD | 2 | 1.1 | 1.1 | 88.5 |
| OCD and LD | 1 | 0.6 | 0.6 | 89.1 |
| Pervasive developmental disorder | 2 | 1.1 | 1.1 | 90.2 |
| Seizure disorder | 1 | 0.6 | 0.6 | 90.8 |
| TBI | 15 | 8.6 | 8.6 | 99.4 |
| Vascular dementia and depression | 1 | 0.6 | 0.6 | 100.0 |
| Total | 174 | 100.0 | 100.0 |